Why Your Ovulation Test Is Always Positive With PCOS

Why Does a PCOS Ovulation Test Read Positive So Often?

Seventy-five percent of women with anovulatory PCOS had a pooled LH level above the normal range, and 94% had an elevated LH-to-FSH ratio, in a study of 61 women with PCOS compared against 24 cycling controls who had blood sampled every 10 minutes for 8–12 hours to map their actual hormone pattern. An ovulation predictor kit (OPK) is built on one assumption: LH sits low for most of the cycle, then spikes sharply 24–36 hours before ovulation, and the test flags that spike crossing a fixed line. When baseline LH is already close to that line before any surge happens, an ordinary day-to-day wobble in an already-elevated hormone is enough to trip the test.

That is the entire mechanism behind “always positive.” It is not a manufacturing defect, a bad batch of sticks, or a reading error — the kit is reporting a true LH value, accurately, against a threshold that was calibrated for a population whose baseline sits much lower. The same elevated LH-to-FSH ratio that shows up on a diagnostic blood panel is the reason the at-home version of the same hormone behaves this way too.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same hormone pattern — only the label changed. This article uses PCOS, since that is still the term most readers search.

What Actually Counts as a False Positive on an OPK?

A false positive, precisely defined, is a test line crossing the kit’s detection threshold without a genuine pre-ovulatory LH surge behind it — not a test that is simply reading LH at all. Urinary LH testing performed well as a predictor of ovulation in a broader comparison study, preceding follicular rupture on ultrasound in all monitored cycles and agreeing with the ultrasound-confirmed timing in 98 of 101 cases — but that accuracy was measured in a population without PCOS’s elevated baseline. In PCOS, the same kit chemistry is asked to detect a spike on top of a baseline that may already sit at or near the cutoff, which is a fundamentally harder signal-detection problem than the one the kit was validated against.

Two different presentations get lumped together under “my test is always positive,” and they call for different responses. A test that reads a consistent, unchanging degree of positivity day after day, with no clear escalation, is more likely reflecting an elevated baseline than a genuine surge — that pattern rarely lines up with actual ovulation timing. A test that reads faintly positive for several days and then noticeably darkens before fading again is more likely showing a real surge riding on top of an elevated baseline — the surge is there, it is just harder to see against the background. Digital kits that report a simple “yes/no” result make this distinction impossible to see at all, since they collapse a continuous hormone value into a binary read; line-based kits that let you compare the test line to the control line day over day preserve more of the actual signal, which matters more in PCOS than in a cycle with a low, stable baseline.

Does LH Baseline Vary by PCOS Phenotype?

Pooled LH correlated inversely with body mass index strongly enough — a correlation of R = -0.59 — that leaner participants in the same 61-woman gonadotropin study tended to run the highest LH levels in the entire sample, while higher-BMI participants ran comparatively, though still often abnormally, lower. That is a specific, practical point for anyone with a lean PCOS presentation: the phenotype most often assumed to be “milder,” because BMI and insulin markers look unremarkable, is often the one furthest from a normal LH baseline — and therefore the group most likely to see an OPK misbehave the most.

Does a High LH Baseline Mean I’m Not Ovulating at All?

No — a chronically elevated LH baseline is a testing problem, not proof of zero ovulation, and conflating the two is the most common misreading of this whole topic. Whether and how often ovulation is actually happening in PCOS, and what that intermittent pattern looks like across a full cycle, is covered in detail in the companion guide on confirming ovulation — the short version is that anovulation in PCOS is usually intermittent rather than absolute, and that distinction has nothing to do with how an OPK behaves.

What follows specifically from the baseline problem is narrower: an OPK cannot be trusted to answer “is ovulation about to happen” on its own in PCOS, regardless of how often it actually occurs. That is a statement about the test’s reliability, not about the person’s fertility, and the two get confused constantly in exactly the way that makes this topic frustrating to search for good information on.

Is There a Way to Make an OPK More Useful in PCOS?

Establishing a personal baseline is the single change that improves an OPK’s usefulness in PCOS the most: testing daily for a full cycle, without acting on any single result, and looking for a rise relative to your own typical reading rather than a rise past the kit’s printed threshold. Because the kit’s fixed cutoff was calibrated against a population with a lower average baseline, a fixed threshold means less in PCOS than a relative change from an individually established normal — a distinctly darker line than the ones you have been seeing for the past week is a stronger signal than any single day’s absolute result. Getting the best time of day and cycle day to actually take the test right is what makes that daily baseline meaningful in the first place — testing at an inconsistent time, or starting too early for a stretched PCOS cycle, adds noise before the baseline comparison even begins.

Pairing the OPK with a confirmatory method closes the remaining gap. Basal body temperature and cervical mucus tracking, timed against whatever the OPK flagged as a possible surge day, either confirm that ovulation followed or show that the positive result was baseline noise. Combining a prediction method with a confirmation method is also what the fertility literature more broadly supports: a 2023 study of 116 subfertile women found that serial hormone measurements, rather than a single point-in-time reading, more accurately predicted the exact day of ovulation, which is the same underlying principle — one measurement in isolation is weaker than a pattern read over several days.

Who This Doesn’t Work For

An OPK, tuned to a personal baseline or not, cannot help someone whose cycles are genuinely anovulatory for extended stretches, because there is no surge — real or masked by baseline noise — for the test to eventually catch. Periods absent for more than three months, or fewer than eight cycles a year, point toward exactly that pattern, and the FIGO ovulatory disorders classification system exists specifically because that kind of sustained ovulatory dysfunction needs clinical evaluation — hormone panels, sometimes ultrasound folliculometry — rather than a better home-testing strategy.

It also will not help someone on hormonal contraception, since ovulation is suppressed by the medication and there is no surge to detect by design, and it offers diminishing value to someone who has already confirmed a reliable ovulatory pattern through BBT or timed progesterone testing across several cycles — at that point, continuing to test daily tends to add anxiety without adding new information.

Common questions